Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C170001-10mg | 10mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $151.90 | |
C170001-25mg | 25mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $339.90 | |
C170001-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,223.90 |
Highly potent, selective A 1 agonist
Synonyms | CCPA|2-Chloro-N6-cyclopentyladenosine|37739-05-2|2-CHLORO-N-CYCLOPENTYLADENOSINE|2-chloro-N(6)cyclopentyladenosine|Adenosine, 2-chloro-N-cyclopentyl-|[3H]CCPA|JX2F2W6WSP|(2R,3R,4S,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3, |
---|---|
Specifications & Purity | 98% |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Action Type | AGONIST |
Mechanism of action | Agonist of A 1 receptor;Agonist of A 2A receptor;Agonist of A 2B receptor;Agonist of A 3 receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (2R,3R,4S,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
---|---|
INCHI | InChI=1S/C15H20ClN5O4/c16-15-19-12(18-7-3-1-2-4-7)9-13(20-15)21(6-17-9)14-11(24)10(23)8(5-22)25-14/h6-8,10-11,14,22-24H,1-5H2,(H,18,19,20)/t8-,10-,11-,14-/m1/s1 |
InChi Key | XSMYYYQVWPZWIZ-IDTAVKCVSA-N |
Canonical SMILES | C1CCC(C1)NC2=C3C(=NC(=N2)Cl)N(C=N3)C4C(C(C(O4)CO)O)O |
Isomeric SMILES | C1CCC(C1)NC2=C3C(=NC(=N2)Cl)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O |
Alternate CAS | 37739-05-2 |
PubChem CID | 123807 |
MeSH Entry Terms | 2-CCPA;2-chloro-N(6)cyclopentyladenosine;CCPA-2;CCPA-2-chloro-N(6)-cyclopentyladenosine;CCPA-2-Cl-N-CPA |
Molecular Weight | 369.8 |
PubChem CID | 123807 |
---|---|
Wikipedia | CCPA_(biochemistry) |
ChEMBL Ligand | CHEMBL284969 |
CAS Registry No. | 37739-05-2 |
GPCRdb Ligand | CCPA |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2105143 | Certificate of Analysis | May 10, 2024 | C170001 |
H2105144 | Certificate of Analysis | May 10, 2024 | C170001 |
H2105145 | Certificate of Analysis | May 10, 2024 | C170001 |
G2219306 | Certificate of Analysis | Jun 06, 2022 | C170001 |
G2219308 | Certificate of Analysis | Jun 06, 2022 | C170001 |
G2219313 | Certificate of Analysis | Jun 06, 2022 | C170001 |
1. Fujimoto K et al.. (2019) Adenosine Attenuates Aortic Smooth Muscle Cell Calcification through A3 Adenosine Receptor.. Tohoku J Exp Med, 249 (4): (275-283). [PMID:31875581] |
2. Yi X et al.. (2018) Adenosine receptors enhance the ATP-induced odontoblastic differentiation of human dental pulp cells.. Biochem Biophys Res Commun, 497 (3): (850-856). [PMID:29454963] |